Trabectedin derivative 2 (TFA)

• Description :

  Trabectedin derivative 2 TFA (compound PL-12) is a Trabectedin derivative that can be used for the study of cancer[1].

• UNSPSC :

  12352211

• Target :

  Drug Derivative

• Related Pathways :

  Others

• Field of Research :

  Cancer

• Purity :

  99.78

• Solubility :

  DMSO : 100 mg/mL

• Smiles :

  N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC=C9N)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O.O=C(O)C(F)(F)F

• Molecular Formula :

  C41H42F3N5O10S

• Molecular Weight :

  853.86

• References & Citations :

  [1]Bin Zou, et al. Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives. WO2024186264A1.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported